Toleranzia AB Company
Toleranzia AB is a technology portfolio for treatment of autoimmune diseases
Technology:
Cell therapy
Industry:
Private
Headquarters:
Gothenburg, Vastra Gotaland, Sweden
Founded Date:
2011-01-01
Employees Number:
1-10
Investors Number:
1
Total Funding:
71429
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-01-01
Last Funding Type:
Grant
Register and Claim Ownership